Efter aflæggelse af Q4 regnskabet afholdt Demant’s ledelse med analytikerne deres investorpræsentation, som kan ses via dette link. Her har man mulighed for at høre Q&A med analytikerne efter ledelsens indledende præsentation.
Demant indleder præsentationen sådan:
- Group LCY growth of 14%, i.e. at the upper end 14% of the most recent outlook range of 12-14%
- Significant recovery in Hearing Healthcare – release of some pent-up demand in Q3 but halt in recovery in Q4 due to new restrictions
- Very strong performance in Communications supported by increased production capacity
- Flat LCY growth in OPEX driven by both temporary and structural savings
- Very strong profitability with EBIT of DKK 1,506 million before EPOS one-offs and EBIT margin of 17.9%
- Very strong cash flows driven by tight working capital management: CFFO of DKK 1,892 million and FCF of DKK 1,534 million
